Feasibility of a Home-Based Exercise Program in Lung and Liver Transplant Recipients for Management of Post-Transplant Metabolic Syndrome: A Pilot Randomized Controlled Trial (Preprint)

Liver Transplant ◽

Controlled Trial ◽

Exercise Program ◽

Transplant Recipients ◽

Randomized Controlled ◽

Home Based ◽

Pilot Randomized Controlled Trial

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

Vaccine ◽

10.1016/j.vaccine.2021.03.063 ◽

2021 ◽

Author(s):

Mari Eriksson ◽

Helena Käyhty ◽

Mika Lahdenkari ◽

Heikki Mäkisalo ◽

Veli-Jukka Anttila

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Repeated Dose ◽

Transplant Recipients ◽

Adult Liver ◽

Randomized Controlled ◽

Conjugate Vaccination

CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled Trial.

Transplantation Journal ◽

10.1097/00007890-199805131-00440 ◽

1998 ◽

Vol 65 (Supplement) ◽

pp. 189

Author(s):

N SINGH ◽

V L YU ◽

T GAYOWSKI ◽

I R MARINO

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Oral Ganciclovir ◽

Transplant Recipients ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Cmv Disease ◽

Cmv Antigenemia

Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial

Infection and Drug Resistance ◽

10.2147/idr.s222934 ◽

2020 ◽

Vol Volume 13 ◽

pp. 89-98

Author(s):

Mojtaba Shafiekhani ◽

Iman Karimzadeh ◽

Saman Nikeghbalian ◽

Mohammad Firoozifar ◽

Gholamreza Pouladfar ◽

...

Keyword(s):

Liver Transplant ◽

Bacterial Infections ◽

Controlled Trial ◽

Transplant Recipients ◽

Post Transplant ◽

Randomized Controlled ◽

CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled Trial

Transplantation Journal ◽

10.1097/00007890-199806270-00461 ◽

1998 ◽

Vol 65 (12) ◽

pp. S113 ◽

Cited By ~ 3

Author(s):

N SINGH ◽

V L YU ◽

T GAYOWSKI ◽

I R MARINO

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Oral Ganciclovir ◽

Transplant Recipients ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Cmv Disease ◽

Cmv Antigenemia

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

American Journal of Transplantation ◽

10.1111/j.1600-6143.2012.04212.x ◽

2012 ◽

Vol 12 (11) ◽

pp. 3008-3020 ◽

Cited By ~ 198

Author(s):

P. De Simone ◽

F. Nevens ◽

L. De Carlis ◽

H. J. Metselaar ◽

S. Beckebaum ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Journal of Hepatology ◽

10.1016/s0168-8278(13)60182-8 ◽

2013 ◽

Vol 58 ◽

pp. S79-S80 ◽

Cited By ~ 2

Author(s):

F. Saliba ◽

H.J. Metselaar ◽

S. Beckebaum ◽

C. Duvoux ◽

M. Navasa ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-015-0626-0 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 8

Author(s):

Bjorn Nashan ◽

Peter Schemmer ◽

Felix Braun ◽

Markus Dworak ◽

Peter Wimmer ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

Study Protocol ◽

De Novo ◽

Controlled Trial ◽

Early Initiation ◽

Transplant Recipients ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955076.793461374 ◽

2012 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Randomized Controlled Trial of Total Immunosuppression Withdrawal in Liver Transplant Recipients: Role of Ursodeoxycholic Acid

Transplantation Journal ◽

10.1097/01.tp.0000266678.32250.76 ◽

2007 ◽

Vol 83 (12) ◽

pp. 1571-1576 ◽

Cited By ~ 47

Author(s):

Nimer Assy ◽

Paul C. Adams ◽

Paul Myers ◽

Verra Simon ◽

Gerry Y. Minuk ◽

...

Keyword(s):

Liver Transplant ◽

Ursodeoxycholic Acid ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

Liver Transplantation ◽

10.1002/lt.21314 ◽

2007 ◽

Vol 13 (12) ◽

pp. 1694-1702 ◽

Cited By ~ 75

Author(s):

Christopher J.E. Watson ◽

Alexander E.S. Gimson ◽

Graeme J. Alexander ◽

Michael E.D. Allison ◽

Paul Gibbs ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

Impaired Renal Function ◽

Calcineurin Inhibitor ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽